Cargando…
A two-year evaluation of the minutes of Investigational New Drug committee meetings
INTRODUCTION: The Investigational New Drug (IND) committee advises the Drug Controller General of India on matters pertaining to clinical trials (CTs) of IND for clinical development. An audit of the minutes of this committee's meetings would shed light on the drug discovery in India. METHODS:...
Autores principales: | Raj, Jeffrey Pradeep, Gogtay, Nithya J., Thatte, Urmila M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525788/ https://www.ncbi.nlm.nih.gov/pubmed/34760647 http://dx.doi.org/10.4103/picr.PICR_83_19 |
Ejemplares similares
-
An evaluation of the minutes of subject expert committee meetings of novel COVID-19 proposals
por: Raj, Jeffrey Pradeep, et al.
Publicado: (2022) -
An audit of minutes of Subject Expert Committee meetings as a metric to assess the clinical research roadmap of India
por: Shetty, Parvan A., et al.
Publicado: (2019) -
An audit of institutional ethics committee queries raised after initial project submission by a single research department at a tertiary referral center in India
por: Raj, Jeffrey Pradeep, et al.
Publicado: (2023) -
An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India
por: Bhide, Shruti S., et al.
Publicado: (2016) -
Compliance of Mumbai-based clinical trial sites with the Quality Council of India guidelines and evaluation of the challenges faced by the investigators
por: Figer, Brinal, et al.
Publicado: (2021)